Blood lead and other metal biomarkers as risk factors for cardiovascular disease mortality

Medicine (United States)

Volumn 95, Issue 1, 2016, Pages

  Aoki, Yutaka ^a   Brody, Debra J ^a   Flegal, Katherine M ^a   Fakhouri, Tala H I ^a   Parker, Jennifer D ^a   Axelrad, Daniel A ^b  

^a NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CADMIUM; HEMOGLOBIN; IRON; LEAD;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL EXAMINATION; ERYTHROCYTE; FEMALE; FOLLOW UP; HEMATOCRIT; HISPANIC; HUMAN; IRON BLOOD LEVEL; LEAD BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; AGED; BLOOD; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DEMOGRAPHY; DRINKING BEHAVIOR; EPIDEMIOLOGY; ETHNOLOGY; MIDDLE AGED; MORTALITY; NUTRITION; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX DIFFERENCE; UNITED STATES;

ADULT; AGED; ALCOHOL DRINKING; BIOMARKERS; C-REACTIVE PROTEIN; CADMIUM; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; HEMATOCRIT; HEMOGLOBINS; HUMANS; IRON; LEAD; MALE; MIDDLE AGED; NUTRITION SURVEYS; PROPORTIONAL HAZARDS MODELS; RESIDENCE CHARACTERISTICS; RISK FACTORS; SEX FACTORS; SMOKING; UNITED STATES;

EID: 84955306542     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000002223     Document Type: Article

References (36)

1. ATSDR. Toxicological Profile for Lead. http://www.atsdr.cdc.gov/toxprofiles/tp13.pdf. Published August, 2007. Accessed November 14, 2014.
2. Schober SE, Mirel LB, Graubard BI, et al. Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study. Environ Health Perspect. 2006;114:1538-1541.
3. Menke A, Muntner P, Batuman V, et al. Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation. 2006;114:1388-1394.
4. Sarnak MJ, Tighiouart H, Manjunath G, et al. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol. 2002;40:27-33.
5. deSilva PE. Blood lead levels and the haematocrit correction. Ann Occup Hygiene. 1984;28:417-428.
6. Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2010. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics. Natl Vital Stat Syst. 2013;61:1-117.
7. National Toxicology, Program. NTP monograph: health effects of low-level lead. NTP Monogr. 2012:i-i148.
8. U.S. EPA. 2013 Final Report: Integrated Science Assessment for Lead. U.S. Environmental Protection Agency, Washington, DC, EPA/600/R-10/075F. http://ofmpub.epa.gov/eims/eimscomm.getfile?p-downloa-d-id=518908. Published June, 2013. Accessed November 14, 2014.
9. CDC. NCHS Data Linked to Mortality Files. http://www.cdc.gov/nchs/data-access/data-linkage/mortality.htm. Accessed November 4, 2014.
10. CDC. NHANES Response Rates and Population Totals. http://www.cdc.gov/nchs/nhanes/response-rates-CPS.htm. Accessed June 15, 2015.
11. National Committee for Clinical Laboratory Standards. Procedure for determining packed cell volume by the micro hematocrit method (NCCLS document H7-A). Villanova, PA, 1985.
12. National Committee for Clinical Laboratory Standards. Reference procedure for the quantitative determination of hemoglobin in blood (NCCLS document H15-A). Villanova, PA, 1984.
13. Miller DT, Paschal DC, Gunter EW, et al. Determination of lead in blood using electrothermal atomisation atomic absorption spectro-metry with a L'vov platform and matrix modifier. Analyst. 1987;112:1701-1704.
14. Parsons PJ, Slavin W. A rapid Zeeman graphite-furnace atomic-absorption spectrometric method for the determination of lead in blood. Spectroc Acta Pt B-Atom Spectr [Article]. 1993;48:925-939.
15. Stoeppler M, Brandt K. Contributions to automated trace analysis Part V. determination of cadmium in whole-blood and urine by electrothermal atomic-absorption spectrophotometry. Fresenius Zeits-chrift Fur Analytische Chemie. 1980;300:372-380.
16. Date AR, Gray AL. Applications of Inductively Coupled Plasma Mass Spectrometry. New York, NY: Chapman and Hall; 1989.
17. CDC. 2009-2010 Data Documentation, Codebook, and Frequencies Standard Biochemistry Profile (BIOPRO-F). http://wwwn.cdc.gov/nchs/nhanes/2009-2010/BIOPRO-F.htm. Accessed December 14, 2014.
18. Sarkar BC, Chauhan UP. A new method for determining micro quantities of calcium in biological materials. Anal Biochem. 1967;20:155-166.
19. Baginski ES, Marie SS, Clark WL, et al. Direct microdetermination of serum calcium. Clin Chim Acta. 1973;46:49-54.
20. CDC. NHANES Laboratory Data. http://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx?Component=Laboratory. Accessed December 9, 2014.
21. Looker AC, Borrud LG, Hughes JP, Fan B, Shepherd JA, Sherman M. Total body bone area, bone mineral content, and bone mineral density for individuals aged 8 years and over: United States, 1999-2006. Vital and health statistics Series 11, Data from the national health survey. 2013:1-86.
22. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol. 1997;145:72-80.
23. Johnson CL, Paulose-Ram R, Ogden CL, et al. National health and nutrition examination survey: analytic guidelines, 1999-2010. Vital and Health Statistics Series 2, Data Evaluation and Methods Research. 2013, 161:1-24.
24. Stata Statistical Software [computer program]. Release 13. College Station, TX: StataCorp LP; 2013.
25. Blood lead levels-United States, 1999-2002. MMWR Morb Mortal Wkly Rep. 2005;54:513-516.
26. CDC. Blood lead levels States, 1988-1991. MMWR Morb Mortal Wkly Rep. 1994;43:545-548.
27. CDC. Fourth National Report on Human Exposure to Environmental Chemicals Updated Tables, August, 2014. http://www.cdc.gov/expo surereport/pdf/fourthreport-updatedtables-aug2014.pdf. Published August, 2014. Accessed December 9, 2014.
28. Hertz-Picciotto I, Croft J. Review of the relation between blood lead and blood pressure. Epidemiol Rev. 1993;15:352-373.
29. Goyer RA. Toxic and essential metal interactions. Ann Rev Nutr. 1997;17:37-50.
30. Corti MC, Guralnik JM, Salive ME, et al. Serum iron level, coronary artery disease, and all-cause mortality in older men and women. Am J Cardiol. 1997;79:120-127.
31. CDC. Second National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population. http://www.cdc.gov/nutritionre-port/pdf/Nutrition-Book-complete508-final.pdf. Published April, 2012. Accessed December 7, 2014.
32. Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Ann Rev Nutr. 2006;26:323-342.
33. Ballew C, Bowman B. Recommending calcium to reduce lead toxicity in children: a critical review. Nutr Rev. 2001;59 (3 Pt 1):71-79.
34. Lutsey PL, Michos ED. Vitamin D, calcium, and atherosclerotic risk: evidence from serum levels and supplementation studies. Curr Atherosclerosis Rep. 2013;15:293.
35. Qu X, Huang X, Jin F, et al. Bone mineral density and all-cause, cardiovascular and stroke mortality: a meta-analysis of prospective cohort studies. Int J Cardiol. 2013;166:385-393.
36. Wong AK, Beattie KA, Bhargava A, et al. Bone lead (Pb) content at the tibia is associated with thinner distal tibia cortices and lower volumetric bone density in postmenopausal women. Bone. 2015;79:58-64.